Anavex Life Sciences Corp (AVXL)

[Anshu2]

Zero. Zero chance this will cross $15 in one year. Zero.

Fools love to dream.

13-14 months since completion of AD trial — which CM proclaimed as “met all co-primary end points!!’. And not an iota of progress (no fda discussions, no P3 plan, forget about NDA!), except for the most crappy CTAD presentation of trial-data in the history of biotech industry! It’s got to be a major major stigma on Stephan McFarlane’s CV.